본문 바로가기

Contact us Download

About UsHistory

1996

Established Biospace Co., Ltd.

1996
Successfully commercialized the world's first body composition analyzer by launching InBody2.0
Dr. Kichul Cha, founder of InBody Co., Ltd succeeded in overcoming the limitations of conventional body composition analysis technology and created the world's first body composition analysis device that was high in accuracy and reproducibility.
This was a great significance for the Korean Technology as it prepared and created a platform for Korean standard technology to be used worldwide.
1997

Established Bioengineering
research center

2000

Established subsidiary
office in the US and Japan

InBody has been actively in the international market from the beginning. InBody has educated and trained their employees as a product expert so that they can start pioneering and developing a market that never existed, and enlightening the customers.

2002

Cheon-An Factory completed

2005

Unified all Body Composition
Analyzer Brands as InBody series

2006
Launched the Home-use body
composition analyzer for home healthcare
To enter into the B2C market and divesity new product line, we launched a home-use body composition analyzer.
We prepared and expanded into the market by marketing the idea that it’s important to cumulatively manage your body composition rather than being a substitute of a weight scale.
2008

Established a subsidiary office in China

2012

Awarded the 10 Million Dollar
Export Tower on Trade Day

2014

Changed the company
name as "InBody Co., Ltd."

2016

Established Subsidiary office
in Malaysia (InBody Asia) & India(InBody India)

2017

Established Subsidiary Office in
Netherlands (InBody Europe)

2017

Expansion of the Cheonan Production Factory
(floors with 22,480 square meter(m2))

2018

InBody Sphygmomanometer 'BPBIO320'
passed the clinical test of the European Society of
Hypertension (ESH) for the first time in Korea

2019

Established a subsidiary office in Mexico